title: Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study.
authors.forename: Nancy E
authors.initials: NE
authors.lastname: Thomas
authors.forename: Peter A
authors.initials: PA
authors.lastname: Kanetsky
authors.forename: Sharon N
authors.initials: SN
authors.lastname: Edmiston
authors.forename: Audrey
authors.initials: A
authors.lastname: Alexander
authors.forename: Colin B
authors.initials: CB
authors.lastname: Begg
authors.forename: Pamela A
authors.initials: PA
authors.lastname: Groben
authors.forename: Honglin
authors.initials: H
authors.lastname: Hao
authors.forename: Klaus
authors.initials: K
authors.lastname: Busam
authors.forename: David W
authors.initials: DW
authors.lastname: Ollila
authors.forename: Marianne
authors.initials: M
authors.lastname: Berwick
authors.forename: Kathleen
authors.initials: K
authors.lastname: Conway
mesh_terms: D014644:Genetic Variation; D018095:Germ-Line Mutation; D006801:Humans; D008545:Melanoma / Q000453:epidemiology / Q000235:genetics*; D009657:North Carolina / Q000453:epidemiology; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D044102:Receptor, Melanocortin, Type 1 / Q000235:genetics*; D012307:Risk Factors; D012878:Skin Neoplasms / Q000453:epidemiology / Q000235:genetics*
chemical_list: D044102:Receptor, Melanocortin, Type 1; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf